Cataract Extraction

1

Review clinical trials related to Cataract Extraction. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

PRO-232 in Patients Subjected to Cataract Surgery

The main objective of this study is to evaluate the efficacy and safety of the PRO-232 formulation manufactured by Laboratorios Sophia S.A. de C.V. on the ocular surface of postoperative cataract patients versus a concomitant administration of ophthalmic moxifloxacin and dexamethasone.

Participants needed: 134
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Laboratorios Sophia S.A de C.V.Updated: Dec 26, 2025Locations: 2
Eligibility criteria

To have the ability to voluntarily grant their signed informed consent (FCI). [+7]

Allergy to any of the components of the investigational products or to any of th... [+27]